Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of valsartan on oxidative stress in type 2 diabetic patients with hypertension
KCT0001498Phase 4Completed
- Sponsor
- Novartis
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of valsartan in type 2 diabetes mellitus (T2DM), hypertension (HTN), sponsored by Novartis. Started Aug 2009; status: completed.
02
Drugs
valsartan
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on KCT0001498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001498.